Skip to content

ADCT - ADC Therapeutics SA - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

ADC Therapeutics SA

ADCT · NYSE

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ADCTADC Therapeutics SA

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $4.98
52-wk low: $0.78
Prev close: $2.95
Mkt cap: $132.8M
Beta: 1.83
P/S: 1.7x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$22.7M

P7
Point72
Steven Cohen · Q2 2026 13F
$3.9M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 42.1% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -121.8%
Market cap: $133M

Valuation

P/S1.67
P/B3.42

Quality

Operating margin-118.1%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ADCT
Exchange: NYSE
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $132.77M
Beta: 1.83

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

3.4x

Profit margin

-121.8%

Op margin

-118.1%

ROE

-706.0%

$3.1M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$2.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ADCT

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.11+42.1%

-$0.19 expected

Next report

What the street expects next

EPS expected

-$0.21

-$0.27 to -$0.19

Revenue expected

$18.9M

5 analysts

Last 30 days

1up1down

Split both ways

-706.0%

ROA-19.6%

Growth

Beta1.83